Weather Update: Our South Austin location will be open from 1 pm to 6 pm on Monday, January 26.
Weather Update: Our South Austin location will be open from 1 pm to 6 pm on Monday, January 26.
As of September 1, 2025, Texans living with chronic pain qualify for medical cannabis. Chronic pain affects approximately 1 in 5 Americans and can significantly impact an individual’s quality of life. Increasing scientific research and testimonials from both physicians and patients indicate that medical cannabis may offer substantial therapeutic benefits and could serve as a safer alternative for managing chronic pain.
Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs | Read More
Marijuana as Medicine? The Science Beyond the Controversy | Read More
The Holistic Effects of Medical Cannabis Compared to Opioids on Pain Experience in Finnish Patients with Chronic Pain | Read More
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems | Read More
Cannabis in Pain Treatment: Clinical and Research Considerations | Read More
The Pharmacology of Cannabinoids in Chronic Pain | Read More
The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain | Read More
Health Outcomes Among Adults Initiating Medical Cannabis for Chronic Pain | Read More
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Alzheimer’s disease (AD) is a complex neurodegenerative disease characterized by the progressive loss of memory and cognitive function. Texas has the third highest Alzheimer's rates, with an estimated 6.9 million Americans aged 65 and older living with Alzheimer's in 2024. Symptoms of Alzheimer’s disease that may respond positively to medical cannabis treatments include sleep problems, paranoia, anxiety, dysphoria, pain, poor appetite, and weight loss. In late-stage Alzheimer’s, medical cannabis may reduce agitation and improve sleep and appetite.
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An Open-Label, Add-On, Pilot Study | Read More
The Potential Therapeutic Effects of THC on Alzheimer’s Disease | Read More
Amyloid Proteotoxicity Initiates an Inflammatory Response Blocked by Cannabinoids | Read More
The Cannabinoid Receptor Agonist Nabilone for the Treatment of Dementia-Related Agitation | Read More
THC for Age-Related Cognitive Decline? | Read More
Cannabinoids Remove Plaque-Forming Alzheimer’s Proteins From Brain Cells | Read More
Cannabinoids for Treatment of Alzheimer’s Disease: Moving Toward the Clinic | Read More
A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology | Read More
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Approximately 449,000+ Texans are living with Autism Spectrum Disorder (ASD). Recent studies suggest that medical cannabis may reduce symptoms such as, hyperactivity, self-injuring behavior, anger, sleep-related difficulties, anxiety, restlessness, agitation, irritability, aggressiveness and depression.
Oral Cannabidiol Use in Children with Autism Spectrum Disorder to Treat Related Symptoms and Co-Morbidities | Read More
Cannabidiol-Based Medical Cannabis in Children with Autism - A Retrospective Feasibility Study | Read More
Real-Life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy | Read More
Evaluation of the Efficacy and Safety of Cannabidiol-Rich Cannabis Extract in Children with Autism Spectrum Disorder | Read More
Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders | Read More
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
As of September 1, 2025, Texans living with chronic pain qualify for medical cannabis. Chronic pain affects approximately 1 in 5 Americans and can significantly impact an individual’s quality of life. Increasing scientific research and testimonials from both physicians and patients indicate that medical cannabis may offer substantial therapeutic benefits and could serve as a safer alternative for managing chronic pain.
Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs | Read More
Marijuana as Medicine? The Science Beyond the Controversy | Read More
The Holistic Effects of Medical Cannabis Compared to Opioids on Pain Experience in Finnish Patients with Chronic Pain | Read More
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems | Read More
Cannabis in Pain Treatment: Clinical and Research Considerations | Read More
The Pharmacology of Cannabinoids in Chronic Pain | Read More
The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain | Read More
Health Outcomes Among Adults Initiating Medical Cannabis for Chronic Pain | Read More
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
There is an increased interest in the use of cannabinoids in the treatment of symptoms in cancer and palliative care patients, including pain, loss of appetite, anxiety, insomnia and nausea. A 2024 survey found that one-third of cancer patients report using cannabis during treatment for symptom relief. In recognition of this growing trend, the American Society of Clinical Oncology released guidance to help clinicians navigate conversations about medical cannabis use for cancer.
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain | Read More
An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics | Read More
Cannabinoids as Therapeutic Agents in Cancer: Current Status and Future Implications | Read More
Cannabis in Palliative Care: Current Challenges and Practical Recommendations | Read More
Update on Prevalence of Pain in Patients with Cancer: Systematic Review and Meta-Analysis | Read More
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review | Read More
Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline | Read More
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience | Read More
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
An estimated 30% to 40% of patients with epilepsy do not respond to traditional medications to manage seizures. Many also worry about the long-term effects of chronic anti-epileptic drug use. Multiple randomized, placebo-controlled trials have shown that medical cannabis can be a safe and effective option for reducing seizure frequency.
Perceived Efficacy of Cannabidiol-enriched Cannabis Extracts for Treatment of Pediatric Epilepsy | Read More
Cannabinoids and Epilepsy | Read More
CBD-enriched Medical Cannabis for Intractable Pediatric Epilepsy | Read More
Efficacy of Artisanal Preparations of Cannabidiol For The Treatment of Epilepsy | Read More
Efficacy of CBD-enriched Medical Cannabis for Treatment of Refractory Epilepsy in Children | Read More
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Huntington's Disease (HD) is caused by a genetic mutation of the HTT gene, with symptom onset between ages 30-50. Cannabinoid receptors are present in high density in the brain, specifically basal ganglia tissues and preclinical studies provide evidence that the regulation of the endocannabinoid system may positively impact various Huntington's symptoms. Multiple studies in animal models have demonstrated symptom relief with cannabinoids and suggest cannabinoids play a role in neuroprotection.
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
As of September 1, 2025, Texans living with IBD and Crohn's disease qualify for medical cannabis. Approximately 115,000 Texans are impacted by Inflammatory Bowel Disease (IBD), a category that includes both Crohn's disease and ulcerative colitis. Recent research suggests that medical cannabis may reduce pain, nausea, inflammation and appetite loss in patients living with inflammatory bowel conditions.
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Recent studies indicate that medical cannabis may offer relief for people living with multiple sclerosis (MS), particularly when using products with balanced levels of CBD and THC. These formulations may help reduce muscle spasticity, pain and other common MS symptoms. In Texas, MS is one of the qualifying conditions for medical cannabis under the Compassionate Use Program, allowing patients to access a natural alternative to commonly prescribed pharmaceuticals.
Multiple Sclerosis and Extract of Cannabis: Results of the MUSEC Trial | Read More
Randomized Controlled Trials of Cannabis-Based Medicine in Spasticity Caused by Multiple Sclerosis | Read More
Randomized, Controlled Trial of Cannabis-based Medicine in Central Pain in Multiple Sclerosis | Read More
Do Cannabis-Based Medicinal Extracts Have General or Specific Effects on Symptoms of Multiple Sclerosis? | Read More
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Extensive preclinical studies in animals with Parkinson’s Disease (PD) provide evidence that regulation of the endocannabinoid system may positively impact various PD symptoms. Cannabinoid receptors are present in high density in the brain, specifically basal ganglia tissues involved in PD. These findings support the potential of cannabinoids to influence both symptom management and disease progression.
Effects of cannabidiol in the treatment of patients with Parkinson’s disease | Read More
Marijuana for Parkinson’s Disease? Innovations in Clinical Science | Read More
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy | Read More
Survey on cannabis use in Parkinson’s disease: subjective improvement of motor symptoms | Read More
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based investigation | Read More
Cannabinoids in Parkinson’s disease | Read More
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection | Read More
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Many Texans experience spasticity and muscle spasms, often linked to conditions like multiple sclerosis (MS), spinal cord injuries, cerebral palsy and other neurological conditions. These involuntary muscle contractions can cause pain, stiffness and reduced mobility, significantly impacting daily life. Recent research suggests that medical cannabis may help relieve spasticity by calming overactive nerves and relaxing muscles. Clinical trials and reviews indicate that cannabinoids like CBD and THC may provide spasm relief comparable to traditional muscle relaxants, with potentially fewer side effects.
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Approximately 2.3 million Texans, including veterans, first responders and civilians, have experienced post-traumatic stress after enduring a traumatic event. Research suggests that medical cannabis may help alleviate PTSD symptoms, including flashbacks, hypervigilance, nightmares and anxiety, by interacting with the endocannabinoid system to regulate stress responses and emotional processing.
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
As of 2021, 1 in 15 Texans lives with neuropathy, a condition that causes chronic pain, numbness and weakness due to nerve damage and can affect people of all ages. Recent research suggests that medical cannabis may help manage neuropathic pain by reducing inflammation, regulating nerve activity and alleviating discomfort. Clinic trials and reviews indicate that compounds found in the cannabis plant, like cannabinoids and terpenes, may offer pain relief comparable to traditional neuropathic pain medications, with potentially fewer side effects.
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
As of September 1, 2025, Texans living with a traumatic brain injury (TBI) qualify for medical cannabis. In Texas, an estimated 144,000 individuals sustain a TBI every year. Research suggests medical cannabis may provide relief for many symptoms that result from traumatic brain injuries, including headaches, nausea, dizziness, fatigue, and more.
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
As of September 1, 2025, patients in palliative care or hospice will qualify for medical cannabis. With zero reported overdose deaths, medical cannabis provides an option for patients who have not responded to traditional treatments, while offering a lower risk of dependency compared to high-risk medications. Research suggests that medical cannabis may help alleviate and improve multiple symptoms, including cancer-related pain, chemotherapy-induced nausea and vomiting, appetite loss, insomnia, depression and more.
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Anxiety, depression and insomnia are not currently approved under the Texas Compassionate Use Program. However, these symptoms are often associated with qualifying conditions. Please consult a healthcare professional to determine your eligibility and appropriate treatment options.
This information is intended for educational purposes only and should not be considered a substitute for medical advice, diagnosis, or treatment. If you have any concerns or questions regarding your health or the use of medical cannabis for your condition, please consult a qualified healthcare professional.
Texas CUP License No. 0005 | © 2026 Texas Original Compassionate Cultivation. | Privacy Policy
